HSA warns against blood glucose supplement containing prescription diabetes drugs

SINGAPORE: The Health Sciences Authority (HSA) recalled “CuraLin advanced glucose support” due to the presence of undisclosed prescription-only antidiabetic medications, glibenclamide and metformin. HSA has instructed LYC Nutrihealth to cease sales and recall affected batches, warning that improper use can lead to severe health risks. Consumers are advised to stop using the product and consult a doctor if adverse effects occur.